SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-04-22 12:53
Tx date 2022-04-18 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-9,000,000 vol 		3,000,000
Filed 2022-04-22 12:52
Tx date 2022-04-18 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-3,187,500 vol 		1,062,500
Filed 2022-04-22 12:52
Tx date 2022-04-18 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-4,537,500 vol 		1,512,500
Filed 2022-04-22 12:51
Tx date 2022-04-18 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-600,000 vol 		200,000
Filed 2022-04-22 12:49
Tx date 2022-04-18 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-5,490,000 vol 		1,830,000
Filed 2022-04-22 12:49
Tx date 2022-04-18 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-3,139,500 vol 		1,046,500
Filed 2022-04-22 12:48
Tx date 2022-04-18 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-4,537,500 vol 		1,512,500
Filed 2021-05-13 15:52
Tx date 2021-05-12 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-6,400
-40,000 vol
$0.16 each 		4,186,000
Filed 2021-05-13 15:51
Tx date 2021-05-12 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-4,080
-24,000 vol
$0.17 each 		4,226,000
Filed 2021-05-11 16:35
Tx date 2021-05-11 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-6,800
-40,000 vol
$0.17 each 		7,320,000
Filed 2021-05-06 12:35
Tx date 2021-05-05 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-7,600
-40,000 vol
$0.19 each 		7,360,000
Filed 2021-05-03 17:55
Tx date 2021-05-03 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-6,970
-34,000 vol
$0.205 each 		7,400,000
Filed 2021-04-30 18:56
Tx date 2021-04-30 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-7,585
-37,000 vol
$0.205 each 		7,434,000
Filed 2021-04-30 18:55
Tx date 2021-04-28 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,890
-9,000 vol
$0.21 each 		7,471,000
Filed 2021-04-26 16:38
Tx date 2021-04-26 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-22,500
-100,000 vol
$0.225 each 		7,480,000
Filed 2021-04-07 17:11
Tx date 2021-04-07 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-4,800
-20,000 vol
$0.24 each 		7,580,000
Filed 2021-04-06 16:53
Tx date 2021-04-06 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-13,800
-60,000 vol
$0.23 each 		7,600,000
Filed 2021-04-06 16:52
Tx date 2021-04-05 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-19,387.50
-82,500 vol
$0.235 each 		7,660,000
Filed 2021-04-06 16:51
Tx date 2021-04-01 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,880
-8,000 vol
$0.235 each 		7,742,500
Filed 2021-02-17 18:01
Tx date 2021-02-16 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-14,355
-49,500 vol
$0.29 each 		7,750,500
Filed 2021-02-02 19:57
Tx date 2021-02-02 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-35,880
-149,500 vol
$0.24 each 		7,800,000
Filed 2021-02-02 19:56
Tx date 2021-02-02 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-2,940
-12,000 vol
$0.245 each 		7,949,500
Filed 2021-02-02 19:55
Tx date 2021-02-02 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-9,625
-38,500 vol
$0.25 each 		7,961,500
Filed 2021-01-21 18:54
Tx date 2020-12-30 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus 		$425,000
+4,250,000 vol
$0.10 each 		4,250,000
Filed 2021-01-21 18:52
Tx date 2020-12-09 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-21 18:50
Tx date 2020-12-30 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$425,000
+4,250,000 vol
$0.10 each 		4,250,000
Filed 2021-01-21 18:47
Tx date 2020-12-09 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-12 18:32
Tx date 2020-12-30 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus 		$205,000
+2,050,000 vol
$0.10 each 		6,050,000
Filed 2021-01-12 18:30
Tx date 2020-12-30 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus 		$205,000
+2,050,000 vol
$0.10 each 		6,050,000
Filed 2020-12-18 23:16
Tx date 2020-12-09 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report 		12,000,000
Filed 2020-12-18 23:16
Tx date 2020-12-09 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		8,000,000
Filed 2020-12-18 23:15
Tx date 2020-12-09 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		800,000
Filed 2020-12-18 23:15
Tx date 2020-12-09 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		4,000,000
Filed 2020-12-18 23:14
Tx date 2020-12-09 		$NEON
NeonMind Biosciences Inc. 		Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		4,000,000
Filed 2018-01-22
Tx date 2018-01-19 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-53,100
-90,000 vol
$0.59 each 		476,500
Filed 2018-01-22
Tx date 2018-01-18 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-53,100
-90,000 vol
$0.59 each 		566,500
Filed 2018-01-18
Tx date 2018-01-16 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-43,771
-65,000 vol
$0.67 each 		681,500
Filed 2018-01-18
Tx date 2018-01-16 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-16,750
-25,000 vol
$0.67 each 		656,500
Filed 2018-01-16
Tx date 2018-01-11 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-18,300
-30,000 vol
$0.61 each 		1,016,500
Filed 2018-01-16
Tx date 2018-01-15 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-53,100
-90,000 vol
$0.59 each 		746,500
Filed 2018-01-16
Tx date 2018-01-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-47,700
-90,000 vol
$0.53 each 		836,500
Filed 2018-01-16
Tx date 2018-01-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-48,042
-90,000 vol
$0.53 each 		926,500
Filed 2018-01-16
Tx date 2018-01-11 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-36,000
-60,000 vol
$0.60 each 		1,046,500
Filed 2018-01-08
Tx date 2018-01-05 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-57,652.65
-85,500 vol
$0.67 each 		1,111,000
Filed 2018-01-08
Tx date 2018-01-05 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,060
-4,500 vol
$0.68 each 		1,106,500
Filed 2018-01-08
Tx date 2018-01-04 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-64,800
-90,000 vol
$0.72 each 		1,196,500
Filed 2017-12-13
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-50,000
-100,000 vol
$0.50 each 		1,436,500
Filed 2017-12-13
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-48,000
-100,000 vol
$0.48 each 		1,286,500
Filed 2017-12-13
Tx date 2017-12-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-27,000
-50,000 vol
$0.54 each 		1,386,500
Filed 2017-09-12
Tx date 2016-11-02 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-12
Tx date 2017-09-10 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		200,000
Filed 2017-06-14
Tx date 2017-06-12 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$92,500
+500,000 vol
$0.185 each 		1,536,500
Filed 2017-04-17
Tx date 2017-04-13 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,315
-73,500 vol
$0.29 each 		1,036,500
Filed 2017-04-10
Tx date 2017-04-05 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$75,000
+500,000 vol
$0.15 each 		1,110,000
Filed 2017-03-31
Tx date 2017-03-30 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-17,550
-90,000 vol
$0.195 each 		610,000
Filed 2017-03-27
Tx date 2017-03-24 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$60,000
+500,000 vol
$0.12 each 		700,000
Filed 2017-01-27
Tx date 2016-11-02 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
99 - Correction of information
+200,000 vol 		400,000
Filed 2017-01-27
Tx date 2017-01-18 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+200,000 vol 		200,000
Filed 2017-01-27
Tx date 2017-01-18 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-14,000
-200,000 vol
$0.07 each 		0
Filed 2017-01-27
Tx date 2017-01-18 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$40,000,000,000
+200,000 vol
$200,000 each 		200,000
Filed 2017-01-18
Tx date 2017-01-09 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-28,000
-200,000 vol
$0.14 each 		0
Filed 2016-12-04
Tx date 2016-11-25 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-14,500
-100,000 vol
$0.145 each 		200,000
Filed 2016-11-17
Tx date 2016-11-15 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-14,000
-200,000 vol
$0.07 each 		0
Filed 2016-11-17
Tx date 2016-11-15 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$14,000
+200,000 vol
$0.07 each 		300,000
Filed 2016-11-17
Tx date 2016-11-14 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services
+100,000 vol 		100,000
Filed 2016-11-17
Tx date 2016-11-02 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-11-07
Tx date 2016-11-02 		$ATT
Abattis Bioceuticals Corp. 		Panenka, William
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		200,000